These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3314763)

  • 1. Should the elderly hypertensive be treated? Evidence from clinical trials.
    Davidson RA; Caranasos GJ
    Arch Intern Med; 1987 Nov; 147(11):1933-7. PubMed ID: 3314763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stroke in the elderly treated for systolic hypertension (SHEP) part II--mortality.
    Singer RB
    J Insur Med; 1992; 24(1):28-31. PubMed ID: 10148474
    [No Abstract]   [Full Text] [Related]  

  • 5. [The intervention trial in the evaluation of antihypertensive therapy].
    Mancia G; Cattaneo BM; Grassi G
    Ann Ital Med Int; 1995 Oct; 10 Suppl():108S-111S. PubMed ID: 8562256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension in the elderly.
    Kendall MJ
    Basic Res Cardiol; 1998; 93 Suppl 2():43-6. PubMed ID: 9833161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large therapeutic studies in elderly patients with hypertension.
    Orozco-Valero M
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S38-43. PubMed ID: 11986892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of elderly hypertension with Ca channel blockers].
    Saito F; Kushiro T
    Clin Calcium; 2005 Oct; 15(10):1717-25. PubMed ID: 16199919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive therapy in the elderly: results of large trials].
    Leonetti G; Cuspidi C; Facchini M
    Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Benefits of hypertension treatment in the elderly].
    Girerd X; Hanon O
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):518-22. PubMed ID: 12555376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of hypertension and cerebrovascular disease in the elderly.
    Pedelty L; Gorelick PB
    Am J Med; 2008 Aug; 121(8 Suppl):S23-31. PubMed ID: 18638616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and differential antihypertensive therapies.
    Os I
    Acta Med Austriaca; 1995; 22(3):45-7. PubMed ID: 8571750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The best of arterial hypertension in 1999].
    Milon H
    Arch Mal Coeur Vaiss; 2000 Jan; 93(1 Spec No):9-15. PubMed ID: 10721443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood pressure and the prevention of stroke.
    MacMahon S
    J Hypertens Suppl; 1996 Dec; 14(6):S39-46. PubMed ID: 9023715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure levels, risk factors and antihypertensive treatments: lessons from the SHEAF study.
    Mallion JM; Genès N; Vaur L; Clerson P; Vaïsse B; Bobrie G; Chatellier G
    J Hum Hypertens; 2001 Dec; 15(12):841-8. PubMed ID: 11773986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hidden truth: what do the clinical trials really tell us about BP control?
    Ruilope LM
    J Hum Hypertens; 1995 Jul; 9 Suppl 2():S3-7. PubMed ID: 7562896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.